フロセミドAPIのグローバル市場予測2023-2029

◆英語タイトル:Global Furosemide API Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23OT1345)◆商品コード:LP23OT1345
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年10月
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「フロセミドAPIのグローバル市場」は、過去の販売実績から2022年の世界のフロセミドAPIの総販売量を検討し、2023年から2029年の予測されるフロセミドAPIの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のフロセミドAPIの市場規模を掲載し、XXX百万米ドル規模の世界のフロセミドAPI市場の詳細な分析を提供します。本インサイトレポートは、世界のフロセミドAPI業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のフロセミドAPI市場における各社の独自のポジションをより深く理解するために、フロセミドAPI製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のフロセミドAPI市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。フロセミドAPIの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。フロセミドAPIの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。フロセミドAPIのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

フロセミドAPIの世界主要メーカーとしては、Kalintis Healthcare Pvt Ltd、 Curia India Private Limited、 Sri Krishna Pharmaceuticals Ltd、 Euroapi Germany Gmbh、 Ipca Laboratories Ltd、 Fis Fabbrica Italiana Sintetici Spa、 Olon S.P.A.、 Teva Pharmaceutical Industries Ltd、 Mangalam Drugs & Organics Ltd.、 Assia Chemical Industries Ltd、 Guangzhou Baiyunshan Pharmaceutical、 Beijing Taiyang Pharmaceutical Industry、 NORTHEAST Pharmaceutical Groupなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のフロセミドAPI市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査ではフロセミドAPI市場をセグメンテーションし、種類別 (純度≧99%、純度<99%)、用途別 (注射剤、錠剤、液剤)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。 ・種類別区分:純度≧99%、純度<99% ・用途別区分:注射剤、錠剤、液剤 ・地域別区分 南北アメリカ(米国、カナダ、メキシコ、ブラジル) アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア) ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア) 中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国) 【本レポートで扱う主な質問】 ・世界のフロセミドAPI市場の10年間の市場状況・展望は? ・世界および地域別に見たフロセミドAPI市場成長の要因は何か? ・フロセミドAPIの市場機会はエンドマーケットの規模によってどのように変化するのか? ・フロセミドAPIのタイプ別、用途別の内訳は? ・新型コロナウイルスとロシア・ウクライナ戦争の影響は? ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要:フロセミドAPIの年間販売量2018-2029、地域別現状・将来分析 ・フロセミドAPIの種類別セグメント:純度≧99%、純度<99% ・フロセミドAPIの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格 ・フロセミドAPIの用途別セグメント:注射剤、錠剤、液剤 ・フロセミドAPIの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格 企業別世界のフロセミドAPI市場 ・企業別のグローバルフロセミドAPI市場データ:2018-2023年の年間販売量、市場シェア ・企業別のフロセミドAPIの年間売上:2018-2023年の売上、市場シェア ・企業別のフロセミドAPI販売価格 ・主要企業のフロセミドAPI生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 フロセミドAPIの地域別レビュー ・地域別のフロセミドAPI市場規模2018-2023:年間販売量、売上 ・主要国別のフロセミドAPI市場規模2018-2023:年間販売量、売上 ・南北アメリカのフロセミドAPI販売の成長 ・アジア太平洋のフロセミドAPI販売の成長 ・ヨーロッパのフロセミドAPI販売の成長 ・中東・アフリカのフロセミドAPI販売の成長 南北アメリカ市場 ・南北アメリカの国別のフロセミドAPI販売量、売上(2018-2023) ・南北アメリカのフロセミドAPIの種類別販売量 ・南北アメリカのフロセミドAPIの用途別販売量 ・米国市場 ・カナダ市場 ・メキシコ市場 ・ブラジル市場 アジア太平洋市場 ・アジア太平洋の国別のフロセミドAPI販売量、売上(2018-2023) ・アジア太平洋のフロセミドAPIの種類別販売量 ・アジア太平洋のフロセミドAPIの用途別販売量 ・中国市場 ・日本市場 ・韓国市場 ・東南アジア市場 ・インド市場 ・オーストラリア市場 ・台湾市場 ヨーロッパ市場 ・ヨーロッパの国別のフロセミドAPI販売量、売上(2018-2023) ・ヨーロッパのフロセミドAPIの種類別販売量 ・ヨーロッパのフロセミドAPIの用途別販売量 ・ドイツ市場 ・フランス市場 ・イギリス市場 ・イタリア市場 ・ロシア市場 中東・アフリカ市場 ・中東・アフリカの国別のフロセミドAPI販売量、売上(2018-2023) ・中東・アフリカのフロセミドAPIの種類別販売量 ・中東・アフリカのフロセミドAPIの用途別販売量 ・エジプト市場 ・南アフリカ市場 ・イスラエル市場 ・トルコ市場 ・GCC諸国市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・フロセミドAPIの製造コスト構造分析 ・フロセミドAPIの製造プロセス分析 ・フロセミドAPIの産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル:直接販売チャンネル、間接販売チャンネル ・フロセミドAPIの主要なグローバル販売業者 ・フロセミドAPIの主要なグローバル顧客 地域別のフロセミドAPI市場予測レビュー ・地域別のフロセミドAPI市場規模予測(2024-2029) ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・ヨーロッパの国別予測 ・フロセミドAPIの種類別市場規模予測 ・フロセミドAPIの用途別市場規模予測 主要企業分析 Kalintis Healthcare Pvt Ltd、 Curia India Private Limited、 Sri Krishna Pharmaceuticals Ltd、 Euroapi Germany Gmbh、 Ipca Laboratories Ltd、 Fis Fabbrica Italiana Sintetici Spa、 Olon S.P.A.、 Teva Pharmaceutical Industries Ltd、 Mangalam Drugs & Organics Ltd.、 Assia Chemical Industries Ltd、 Guangzhou Baiyunshan Pharmaceutical、 Beijing Taiyang Pharmaceutical Industry、 NORTHEAST Pharmaceutical Group ・企業情報 ・フロセミドAPI製品 ・フロセミドAPI販売量、売上、価格、粗利益(2018-2023) ・主要ビジネス概要 ・最新動向 調査結果および結論

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Furosemide API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Furosemide API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Furosemide API by Country/Region, 2018, 2022 & 2029
2.2 Furosemide API Segment by Type
2.2.1 Purity≥99%
2.2.2 Purity<99% 2.3 Furosemide API Sales by Type 2.3.1 Global Furosemide API Sales Market Share by Type (2018-2023) 2.3.2 Global Furosemide API Revenue and Market Share by Type (2018-2023) 2.3.3 Global Furosemide API Sale Price by Type (2018-2023) 2.4 Furosemide API Segment by Application 2.4.1 Injection 2.4.2 Tablet 2.4.3 Solution 2.5 Furosemide API Sales by Application 2.5.1 Global Furosemide API Sale Market Share by Application (2018-2023) 2.5.2 Global Furosemide API Revenue and Market Share by Application (2018-2023) 2.5.3 Global Furosemide API Sale Price by Application (2018-2023) 3 Global Furosemide API by Company 3.1 Global Furosemide API Breakdown Data by Company 3.1.1 Global Furosemide API Annual Sales by Company (2018-2023) 3.1.2 Global Furosemide API Sales Market Share by Company (2018-2023) 3.2 Global Furosemide API Annual Revenue by Company (2018-2023) 3.2.1 Global Furosemide API Revenue by Company (2018-2023) 3.2.2 Global Furosemide API Revenue Market Share by Company (2018-2023) 3.3 Global Furosemide API Sale Price by Company 3.4 Key Manufacturers Furosemide API Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Furosemide API Product Location Distribution 3.4.2 Players Furosemide API Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Furosemide API by Geographic Region 4.1 World Historic Furosemide API Market Size by Geographic Region (2018-2023) 4.1.1 Global Furosemide API Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Furosemide API Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Furosemide API Market Size by Country/Region (2018-2023) 4.2.1 Global Furosemide API Annual Sales by Country/Region (2018-2023) 4.2.2 Global Furosemide API Annual Revenue by Country/Region (2018-2023) 4.3 Americas Furosemide API Sales Growth 4.4 APAC Furosemide API Sales Growth 4.5 Europe Furosemide API Sales Growth 4.6 Middle East & Africa Furosemide API Sales Growth 5 Americas 5.1 Americas Furosemide API Sales by Country 5.1.1 Americas Furosemide API Sales by Country (2018-2023) 5.1.2 Americas Furosemide API Revenue by Country (2018-2023) 5.2 Americas Furosemide API Sales by Type 5.3 Americas Furosemide API Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Furosemide API Sales by Region 6.1.1 APAC Furosemide API Sales by Region (2018-2023) 6.1.2 APAC Furosemide API Revenue by Region (2018-2023) 6.2 APAC Furosemide API Sales by Type 6.3 APAC Furosemide API Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Furosemide API by Country 7.1.1 Europe Furosemide API Sales by Country (2018-2023) 7.1.2 Europe Furosemide API Revenue by Country (2018-2023) 7.2 Europe Furosemide API Sales by Type 7.3 Europe Furosemide API Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Furosemide API by Country 8.1.1 Middle East & Africa Furosemide API Sales by Country (2018-2023) 8.1.2 Middle East & Africa Furosemide API Revenue by Country (2018-2023) 8.2 Middle East & Africa Furosemide API Sales by Type 8.3 Middle East & Africa Furosemide API Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Furosemide API 10.3 Manufacturing Process Analysis of Furosemide API 10.4 Industry Chain Structure of Furosemide API 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Furosemide API Distributors 11.3 Furosemide API Customer 12 World Forecast Review for Furosemide API by Geographic Region 12.1 Global Furosemide API Market Size Forecast by Region 12.1.1 Global Furosemide API Forecast by Region (2024-2029) 12.1.2 Global Furosemide API Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Furosemide API Forecast by Type 12.7 Global Furosemide API Forecast by Application 13 Key Players Analysis 13.1 Kalintis Healthcare Pvt Ltd 13.1.1 Kalintis Healthcare Pvt Ltd Company Information 13.1.2 Kalintis Healthcare Pvt Ltd Furosemide API Product Portfolios and Specifications 13.1.3 Kalintis Healthcare Pvt Ltd Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Kalintis Healthcare Pvt Ltd Main Business Overview 13.1.5 Kalintis Healthcare Pvt Ltd Latest Developments 13.2 Curia India Private Limited 13.2.1 Curia India Private Limited Company Information 13.2.2 Curia India Private Limited Furosemide API Product Portfolios and Specifications 13.2.3 Curia India Private Limited Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Curia India Private Limited Main Business Overview 13.2.5 Curia India Private Limited Latest Developments 13.3 Sri Krishna Pharmaceuticals Ltd 13.3.1 Sri Krishna Pharmaceuticals Ltd Company Information 13.3.2 Sri Krishna Pharmaceuticals Ltd Furosemide API Product Portfolios and Specifications 13.3.3 Sri Krishna Pharmaceuticals Ltd Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Sri Krishna Pharmaceuticals Ltd Main Business Overview 13.3.5 Sri Krishna Pharmaceuticals Ltd Latest Developments 13.4 Euroapi Germany Gmbh 13.4.1 Euroapi Germany Gmbh Company Information 13.4.2 Euroapi Germany Gmbh Furosemide API Product Portfolios and Specifications 13.4.3 Euroapi Germany Gmbh Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Euroapi Germany Gmbh Main Business Overview 13.4.5 Euroapi Germany Gmbh Latest Developments 13.5 Ipca Laboratories Ltd 13.5.1 Ipca Laboratories Ltd Company Information 13.5.2 Ipca Laboratories Ltd Furosemide API Product Portfolios and Specifications 13.5.3 Ipca Laboratories Ltd Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Ipca Laboratories Ltd Main Business Overview 13.5.5 Ipca Laboratories Ltd Latest Developments 13.6 Fis Fabbrica Italiana Sintetici Spa 13.6.1 Fis Fabbrica Italiana Sintetici Spa Company Information 13.6.2 Fis Fabbrica Italiana Sintetici Spa Furosemide API Product Portfolios and Specifications 13.6.3 Fis Fabbrica Italiana Sintetici Spa Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Fis Fabbrica Italiana Sintetici Spa Main Business Overview 13.6.5 Fis Fabbrica Italiana Sintetici Spa Latest Developments 13.7 Olon S.P.A. 13.7.1 Olon S.P.A. Company Information 13.7.2 Olon S.P.A. Furosemide API Product Portfolios and Specifications 13.7.3 Olon S.P.A. Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Olon S.P.A. Main Business Overview 13.7.5 Olon S.P.A. Latest Developments 13.8 Teva Pharmaceutical Industries Ltd 13.8.1 Teva Pharmaceutical Industries Ltd Company Information 13.8.2 Teva Pharmaceutical Industries Ltd Furosemide API Product Portfolios and Specifications 13.8.3 Teva Pharmaceutical Industries Ltd Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Teva Pharmaceutical Industries Ltd Main Business Overview 13.8.5 Teva Pharmaceutical Industries Ltd Latest Developments 13.9 Mangalam Drugs & Organics Ltd. 13.9.1 Mangalam Drugs & Organics Ltd. Company Information 13.9.2 Mangalam Drugs & Organics Ltd. Furosemide API Product Portfolios and Specifications 13.9.3 Mangalam Drugs & Organics Ltd. Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Mangalam Drugs & Organics Ltd. Main Business Overview 13.9.5 Mangalam Drugs & Organics Ltd. Latest Developments 13.10 Assia Chemical Industries Ltd 13.10.1 Assia Chemical Industries Ltd Company Information 13.10.2 Assia Chemical Industries Ltd Furosemide API Product Portfolios and Specifications 13.10.3 Assia Chemical Industries Ltd Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Assia Chemical Industries Ltd Main Business Overview 13.10.5 Assia Chemical Industries Ltd Latest Developments 13.11 Guangzhou Baiyunshan Pharmaceutical 13.11.1 Guangzhou Baiyunshan Pharmaceutical Company Information 13.11.2 Guangzhou Baiyunshan Pharmaceutical Furosemide API Product Portfolios and Specifications 13.11.3 Guangzhou Baiyunshan Pharmaceutical Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Guangzhou Baiyunshan Pharmaceutical Main Business Overview 13.11.5 Guangzhou Baiyunshan Pharmaceutical Latest Developments 13.12 Beijing Taiyang Pharmaceutical Industry 13.12.1 Beijing Taiyang Pharmaceutical Industry Company Information 13.12.2 Beijing Taiyang Pharmaceutical Industry Furosemide API Product Portfolios and Specifications 13.12.3 Beijing Taiyang Pharmaceutical Industry Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Beijing Taiyang Pharmaceutical Industry Main Business Overview 13.12.5 Beijing Taiyang Pharmaceutical Industry Latest Developments 13.13 NORTHEAST Pharmaceutical Group 13.13.1 NORTHEAST Pharmaceutical Group Company Information 13.13.2 NORTHEAST Pharmaceutical Group Furosemide API Product Portfolios and Specifications 13.13.3 NORTHEAST Pharmaceutical Group Furosemide API Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 NORTHEAST Pharmaceutical Group Main Business Overview 13.13.5 NORTHEAST Pharmaceutical Group Latest Developments 14 Research Findings and Conclusion

List of Tables
Table 1. Furosemide API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Furosemide API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity≥99%
Table 4. Major Players of Purity<99%
Table 5. Global Furosemide API Sales by Type (2018-2023) & (Tons)
Table 6. Global Furosemide API Sales Market Share by Type (2018-2023)
Table 7. Global Furosemide API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Furosemide API Revenue Market Share by Type (2018-2023)
Table 9. Global Furosemide API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Furosemide API Sales by Application (2018-2023) & (Tons)
Table 11. Global Furosemide API Sales Market Share by Application (2018-2023)
Table 12. Global Furosemide API Revenue by Application (2018-2023)
Table 13. Global Furosemide API Revenue Market Share by Application (2018-2023)
Table 14. Global Furosemide API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Furosemide API Sales by Company (2018-2023) & (Tons)
Table 16. Global Furosemide API Sales Market Share by Company (2018-2023)
Table 17. Global Furosemide API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Furosemide API Revenue Market Share by Company (2018-2023)
Table 19. Global Furosemide API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Furosemide API Producing Area Distribution and Sales Area
Table 21. Players Furosemide API Products Offered
Table 22. Furosemide API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Furosemide API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Furosemide API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Furosemide API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Furosemide API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Furosemide API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Furosemide API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Furosemide API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Furosemide API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Furosemide API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Furosemide API Sales Market Share by Country (2018-2023)
Table 35. Americas Furosemide API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Furosemide API Revenue Market Share by Country (2018-2023)
Table 37. Americas Furosemide API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Furosemide API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Furosemide API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Furosemide API Sales Market Share by Region (2018-2023)
Table 41. APAC Furosemide API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Furosemide API Revenue Market Share by Region (2018-2023)
Table 43. APAC Furosemide API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Furosemide API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Furosemide API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Furosemide API Sales Market Share by Country (2018-2023)
Table 47. Europe Furosemide API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Furosemide API Revenue Market Share by Country (2018-2023)
Table 49. Europe Furosemide API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Furosemide API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Furosemide API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Furosemide API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Furosemide API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Furosemide API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Furosemide API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Furosemide API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Furosemide API
Table 58. Key Market Challenges & Risks of Furosemide API
Table 59. Key Industry Trends of Furosemide API
Table 60. Furosemide API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Furosemide API Distributors List
Table 63. Furosemide API Customer List
Table 64. Global Furosemide API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Furosemide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Furosemide API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Furosemide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Furosemide API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Furosemide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Furosemide API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Furosemide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Furosemide API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Furosemide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Furosemide API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Furosemide API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Furosemide API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Furosemide API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Kalintis Healthcare Pvt Ltd Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 79. Kalintis Healthcare Pvt Ltd Furosemide API Product Portfolios and Specifications
Table 80. Kalintis Healthcare Pvt Ltd Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Kalintis Healthcare Pvt Ltd Main Business
Table 82. Kalintis Healthcare Pvt Ltd Latest Developments
Table 83. Curia India Private Limited Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 84. Curia India Private Limited Furosemide API Product Portfolios and Specifications
Table 85. Curia India Private Limited Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Curia India Private Limited Main Business
Table 87. Curia India Private Limited Latest Developments
Table 88. Sri Krishna Pharmaceuticals Ltd Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 89. Sri Krishna Pharmaceuticals Ltd Furosemide API Product Portfolios and Specifications
Table 90. Sri Krishna Pharmaceuticals Ltd Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Sri Krishna Pharmaceuticals Ltd Main Business
Table 92. Sri Krishna Pharmaceuticals Ltd Latest Developments
Table 93. Euroapi Germany Gmbh Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 94. Euroapi Germany Gmbh Furosemide API Product Portfolios and Specifications
Table 95. Euroapi Germany Gmbh Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Euroapi Germany Gmbh Main Business
Table 97. Euroapi Germany Gmbh Latest Developments
Table 98. Ipca Laboratories Ltd Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 99. Ipca Laboratories Ltd Furosemide API Product Portfolios and Specifications
Table 100. Ipca Laboratories Ltd Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Ipca Laboratories Ltd Main Business
Table 102. Ipca Laboratories Ltd Latest Developments
Table 103. Fis Fabbrica Italiana Sintetici Spa Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 104. Fis Fabbrica Italiana Sintetici Spa Furosemide API Product Portfolios and Specifications
Table 105. Fis Fabbrica Italiana Sintetici Spa Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Fis Fabbrica Italiana Sintetici Spa Main Business
Table 107. Fis Fabbrica Italiana Sintetici Spa Latest Developments
Table 108. Olon S.P.A. Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 109. Olon S.P.A. Furosemide API Product Portfolios and Specifications
Table 110. Olon S.P.A. Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Olon S.P.A. Main Business
Table 112. Olon S.P.A. Latest Developments
Table 113. Teva Pharmaceutical Industries Ltd Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 114. Teva Pharmaceutical Industries Ltd Furosemide API Product Portfolios and Specifications
Table 115. Teva Pharmaceutical Industries Ltd Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Teva Pharmaceutical Industries Ltd Main Business
Table 117. Teva Pharmaceutical Industries Ltd Latest Developments
Table 118. Mangalam Drugs & Organics Ltd. Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 119. Mangalam Drugs & Organics Ltd. Furosemide API Product Portfolios and Specifications
Table 120. Mangalam Drugs & Organics Ltd. Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Mangalam Drugs & Organics Ltd. Main Business
Table 122. Mangalam Drugs & Organics Ltd. Latest Developments
Table 123. Assia Chemical Industries Ltd Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 124. Assia Chemical Industries Ltd Furosemide API Product Portfolios and Specifications
Table 125. Assia Chemical Industries Ltd Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Assia Chemical Industries Ltd Main Business
Table 127. Assia Chemical Industries Ltd Latest Developments
Table 128. Guangzhou Baiyunshan Pharmaceutical Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 129. Guangzhou Baiyunshan Pharmaceutical Furosemide API Product Portfolios and Specifications
Table 130. Guangzhou Baiyunshan Pharmaceutical Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Guangzhou Baiyunshan Pharmaceutical Main Business
Table 132. Guangzhou Baiyunshan Pharmaceutical Latest Developments
Table 133. Beijing Taiyang Pharmaceutical Industry Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 134. Beijing Taiyang Pharmaceutical Industry Furosemide API Product Portfolios and Specifications
Table 135. Beijing Taiyang Pharmaceutical Industry Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Beijing Taiyang Pharmaceutical Industry Main Business
Table 137. Beijing Taiyang Pharmaceutical Industry Latest Developments
Table 138. NORTHEAST Pharmaceutical Group Basic Information, Furosemide API Manufacturing Base, Sales Area and Its Competitors
Table 139. NORTHEAST Pharmaceutical Group Furosemide API Product Portfolios and Specifications
Table 140. NORTHEAST Pharmaceutical Group Furosemide API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. NORTHEAST Pharmaceutical Group Main Business
Table 142. NORTHEAST Pharmaceutical Group Latest Developments
List of Figures
Figure 1. Picture of Furosemide API
Figure 2. Furosemide API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Furosemide API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Furosemide API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Furosemide API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity≥99%
Figure 10. Product Picture of Purity<99%
Figure 11. Global Furosemide API Sales Market Share by Type in 2022
Figure 12. Global Furosemide API Revenue Market Share by Type (2018-2023)
Figure 13. Furosemide API Consumed in Injection
Figure 14. Global Furosemide API Market: Injection (2018-2023) & (Tons)
Figure 15. Furosemide API Consumed in Tablet
Figure 16. Global Furosemide API Market: Tablet (2018-2023) & (Tons)
Figure 17. Furosemide API Consumed in Solution
Figure 18. Global Furosemide API Market: Solution (2018-2023) & (Tons)
Figure 19. Global Furosemide API Sales Market Share by Application (2022)
Figure 20. Global Furosemide API Revenue Market Share by Application in 2022
Figure 21. Furosemide API Sales Market by Company in 2022 (Tons)
Figure 22. Global Furosemide API Sales Market Share by Company in 2022
Figure 23. Furosemide API Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Furosemide API Revenue Market Share by Company in 2022
Figure 25. Global Furosemide API Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Furosemide API Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Furosemide API Sales 2018-2023 (Tons)
Figure 28. Americas Furosemide API Revenue 2018-2023 ($ Millions)
Figure 29. APAC Furosemide API Sales 2018-2023 (Tons)
Figure 30. APAC Furosemide API Revenue 2018-2023 ($ Millions)
Figure 31. Europe Furosemide API Sales 2018-2023 (Tons)
Figure 32. Europe Furosemide API Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Furosemide API Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Furosemide API Revenue 2018-2023 ($ Millions)
Figure 35. Americas Furosemide API Sales Market Share by Country in 2022
Figure 36. Americas Furosemide API Revenue Market Share by Country in 2022
Figure 37. Americas Furosemide API Sales Market Share by Type (2018-2023)
Figure 38. Americas Furosemide API Sales Market Share by Application (2018-2023)
Figure 39. United States Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Furosemide API Sales Market Share by Region in 2022
Figure 44. APAC Furosemide API Revenue Market Share by Regions in 2022
Figure 45. APAC Furosemide API Sales Market Share by Type (2018-2023)
Figure 46. APAC Furosemide API Sales Market Share by Application (2018-2023)
Figure 47. China Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Furosemide API Sales Market Share by Country in 2022
Figure 55. Europe Furosemide API Revenue Market Share by Country in 2022
Figure 56. Europe Furosemide API Sales Market Share by Type (2018-2023)
Figure 57. Europe Furosemide API Sales Market Share by Application (2018-2023)
Figure 58. Germany Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Furosemide API Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Furosemide API Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Furosemide API Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Furosemide API Sales Market Share by Application (2018-2023)
Figure 67. Egypt Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Furosemide API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Furosemide API in 2022
Figure 73. Manufacturing Process Analysis of Furosemide API
Figure 74. Industry Chain Structure of Furosemide API
Figure 75. Channels of Distribution
Figure 76. Global Furosemide API Sales Market Forecast by Region (2024-2029)
Figure 77. Global Furosemide API Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Furosemide API Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Furosemide API Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Furosemide API Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Furosemide API Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ フロセミドAPIのグローバル市場予測2023-2029(Global Furosemide API Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆